Edgewise Therapeutics, Inc. (EWTX)
40.45
+0.92
(+2.33%)
USD |
NASDAQ |
Oct 28, 16:00
40.45
0.00 (0.00%)
After-Hours: 18:34
Edgewise Therapeutics Price to Book Value : 9.729 for Oct. 28, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 9.508 |
| October 26, 2026 | 9.422 |
| October 23, 2026 | 9.455 |
| October 22, 2026 | 9.619 |
| October 21, 2026 | 9.537 |
| October 20, 2026 | 9.561 |
| October 19, 2026 | 9.121 |
| October 16, 2026 | 8.945 |
| October 15, 2026 | 9.188 |
| October 14, 2026 | 8.904 |
| October 13, 2026 | 8.726 |
| October 12, 2026 | 9.248 |
| October 09, 2026 | 9.395 |
| October 08, 2026 | 9.436 |
| October 07, 2026 | 9.518 |
| October 06, 2026 | 9.626 |
| October 05, 2026 | 9.693 |
| October 02, 2026 | 9.958 |
| October 01, 2026 | 9.737 |
| September 30, 2026 | 9.766 |
| September 29, 2026 | 9.426 |
| September 28, 2026 | 9.571 |
| September 25, 2026 | 9.462 |
| September 24, 2026 | 9.900 |
| September 23, 2026 | 9.874 |
| Date | Value |
|---|---|
| September 22, 2026 | 10.71 |
| September 21, 2026 | 10.74 |
| September 18, 2026 | 10.90 |
| September 17, 2026 | 11.29 |
| September 16, 2026 | 10.93 |
| September 15, 2026 | 10.49 |
| September 14, 2026 | 10.73 |
| September 11, 2026 | 10.68 |
| September 10, 2026 | 10.32 |
| September 09, 2026 | 10.44 |
| September 08, 2026 | 10.54 |
| September 04, 2026 | 10.36 |
| September 03, 2026 | 10.09 |
| September 02, 2026 | 10.10 |
| September 01, 2026 | 10.16 |
| August 31, 2026 | 10.05 |
| August 28, 2026 | 10.29 |
| August 27, 2026 | 10.63 |
| August 26, 2026 | 10.67 |
| August 25, 2026 | 10.63 |
| August 24, 2026 | 10.76 |
| August 21, 2026 | 10.63 |
| August 20, 2026 | 10.41 |
| August 19, 2026 | 11.17 |
| August 18, 2026 | 10.61 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 13.21 |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | 0.8816 |
| Fulcrum Therapeutics, Inc. | 0.9257 |
| Definium Therapeutics, Inc. | 5.572 |
Price to Book Value Related Metrics
| PEG Ratio | -1.159 |
| Price | 40.45 |
| Earnings Yield | -4.57% |
| Market Cap | 4.360B |
| PEGY Ratio | -1.159 |